Siva Sai Krishna Dasa

Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer

Siva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki et al. · Theranostics · 2018 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction

Siva Sai Krishna Dasa, Ryo Suzuki, Michael Gutknecht et al. · Journal of Controlled Release · 2015 · 67 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16

PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing

Lindsey T. Brinton, Dustin K. Bauknight, Siva Sai Krishna Dasa · PLoS ONE · 2016 · 46 citations · Full text

Pharmacy, Oncology, Drug Discovery +16

Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging

Zibo Li, Qiaoling Jin, Chiun‐Wei Huang et al. · Theranostics · 2011 · 33 citations · Full text

Medicine, Bioengineering, Nuclear Medicine +17

<i>In vivo</i> liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects

Victoria Osinski, Dustin K. Bauknight, Siva Sai Krishna Dasa et al. · Theranostics · 2019 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17